布伦图西马布维多丁在霍奇金淋巴瘤的成本效益:系统性审查
Jalal Arabloo1, Samad Azari2, Hasan Abolghasem Gorji3
1Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran. arabloo.j@iums.ac.ir.
European journal of clinical pharmacology
|September 1, 2023
概括
布伦图西马布维多丁 (BV) 不是霍奇金淋巴瘤 (HL) 前线或复发/耐药治疗的成本效益. 在决策过程中,应权衡临床益处和替代疗法,以及成本效益.
科学领域:
- 药物经济学 药物经济学
- 在瘤学瘤学.
- 卫生技术评估 卫生技术评估
背景情况:
- 霍奇金淋巴瘤 (HL) 治疗涉及复杂的治疗决策.
- 布伦图西马布维多丁 (BV) 是一种用于HL治疗的孤儿药物.
- 评估像BV这样的新疗法的成本效益对于医疗保健资源分配至关重要.
结论:
- 目前的经济评估表明,BV在既定门下对前线或R / R HL治疗不具有成本效益.
- 除了成本效益之外的因素,如替代疗法,临床益处和疾病负担,应决定BV的使用.
- 可能需要进一步的药物经济分析来澄清BV在特定HL患者群体中的价值.
更多相关视频
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.4K
11:31Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System
Published on: August 8, 2012
25.1K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
